Dagard Ventures into Indian Market at French Healthcare Days 2024

Dagard, a French leader in insulating solutions, will participate in the French Healthcare Days 2024 in India, showcasing its expertise in cleanrooms for pharmaceuticals and healthcare. With plans to engage in B2B meetings, Dagard aims to introduce its innovative, sustainable solutions to the Indian market.

Dagard, a major French player in insulating solutions and controlled atmospheres, is eyeing the Indian market as it prepares to participate in the French Healthcare Days 2024 programme. Organised by Business France India - The Trade Commission of France in India, the event will take place from 17-19 September, featuring B2B meetings led by Baudoin Feugere des Forts, Dagard's Head of Exports.

Established in 1951 and now part of Purever Industries, Dagard has built a reputation for designing, manufacturing, marketing, and installing innovative and sustainable solutions. Renowned for its cleanrooms that prevent contamination, the company has been pivotal in numerous life sciences, healthcare, and pharmaceutical projects.

India's pharmaceutical, biotechnology, hospital, and laboratory sectors face significant contamination risks requiring robust construction systems to maintain controlled environments. Dagard's solutions meet these needs by ensuring optimal air quality, temperature, humidity, and pressure. Their Ultra-Clean and Controlled Environment ranges are lauded for their efficiency and ease of installation, making them ideal for sensitive applications.

Employing over 400 professionals, Dagard offers comprehensive customer support from project consultation to after-sales service. With extensive expertise and ongoing R&D investment, the company continues to innovate, addressing the evolving needs of its clients. Highlights of their work include the Nanoscience and Nanotechnology Centre (C2N) at Paris Saclay, a leading European hub for nanoscience and nanotechnologies.

Dagard's participation in French Healthcare Days signals a strategic move to expand into the Indian market, bringing its cutting-edge solutions to the country's burgeoning healthcare and pharmaceutical sectors.

(With inputs from agencies.)